Novel insights into proteolytic cleavage of influenza virus hemagglutinin.

Reviews in Medical Virology
Stephanie BertramStefan Pöhlmann

Abstract

The influenza virus hemagglutinin (HA) mediates the first essential step in the viral life cycle, virus entry into target cells. Influenza virus HA is synthesised as a precursor protein in infected cells and requires cleavage by host cell proteases to transit into an active form. Cleavage is essential for influenza virus infectivity and the HA-processing proteases are attractive targets for therapeutic intervention. It is well established that cleavage by ubiquitously expressed subtilisin-like proteases is a hallmark of highly pathogenic avian influenza viruses (HPAIV). In contrast, the nature of the proteases responsible for cleavage of HA of human influenza viruses and low pathogenic avian influenza viruses (LPAIV) is not well understood. Recent studies suggest that cleavage of HA of human influenza viruses might be a cell-associated event and might be facilitated by the type II transmembrane serine proteases (TTSPs) TMPRSS2, TMPRSS4 and human airway trypsin-like protease (HAT). Here, we will introduce the different concepts established for proteolytic activation of influenza virus HA, with a particular focus on the role of TTSPs, and we will discuss their implications for viral tropism, pathogenicity and antiviral intervention.

References

Dec 1, 1975·Virology·H D KlenkJ Blödorn
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K R KlimpelS H Leppla
Oct 1, 1992·The Journal of Infectious Diseases·H ScheiblauerR Rott
Aug 25, 1989·Cell·I de Curtis, K Simons
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·K L DeshpandeR G Webster
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J J SkehelD C Wiley
Feb 1, 1994·Antiviral Research·A V Ovcharenko, O P Zhirnov
Feb 1, 1994·Trends in Microbiology·H D Klenk, W Garten
Feb 1, 1993·Journal of Virology·M R Castrucci, Y Kawaoka
Mar 1, 1997·American Journal of Respiratory Cell and Molecular Biology·S YasuokaT Sano
Oct 8, 1997·Infection and Immunity·V M GordonR K Tweten
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·J K Taubenberger
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·H Goto, Y Kawaoka
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A H ReidJ K Taubenberger
Apr 21, 1999·Trends in Microbiology·W Garten, H D Klenk
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·A H ReidJ K Taubenberger
Aug 31, 2000·Annual Review of Biochemistry·J J Skehel, D C Wiley
Apr 27, 2001·European Journal of Biochemistry·E JacquinetJ R Hoidal
May 1, 2001·Histochemistry and Cell Biology·M TakahashiS Yasuoka

❮ Previous
Next ❯

Citations

Jun 6, 2013·Virus Research·Stephanie SonnbergRobert G Webster
Dec 19, 2013·PloS One·Boerries BrandenburgRobert H E Friesen
Dec 19, 2013·PLoS Pathogens·Bastian HatesuerKlaus Schughart
Jan 25, 2013·Viruses·Heike Hofmann-WinklerStefan Pöhlmann
Oct 1, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E J A SchrauwenR A M Fouchier
Feb 1, 2013·Advances in Virology·Emily Rumschlag-Booms, Lijun Rong
Jun 20, 2014·Future Medicinal Chemistry·Chung-Kai ChengJim-Min Fang
Dec 27, 2011·Trends in Pharmacological Sciences·Konstantin H MüllerDenis E Kainov
Feb 18, 2016·Advances in Virology·Shahla ShahsavandiHasan Izadi
Jun 27, 2013·Medicinal Research Reviews·Evelien Vanderlinden, Lieve Naesens
Nov 19, 2013·The Journal of General Virology·Carrie M RosenbergerAlan Aderem
Mar 31, 2015·Virology·T Enkirch, V von Messling
May 27, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Marie-Laure FoucaultBéatrice Riteau
Mar 19, 2015·BioMed Research International·Anwar M Hashem
Sep 10, 2014·British Journal of Cancer·A L de Aberasturi, A Calvo
Jul 19, 2016·Influenza and Other Respiratory Viruses·Udayan JosephGavin J D Smith
Oct 8, 2016·PloS One·Xiang XuGeorge H Caughey
Feb 15, 2018·International Journal of Molecular Sciences·Remigiusz WorchPiotr Setny
Feb 27, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Awen MenouBruno Crestani
Nov 10, 2017·Bulletin of Experimental Biology and Medicine·A A KononovaA G Pokrovskii
Nov 1, 2016·Journal of Virology·Kazuya ShiratoShutoku Matsuyama
Aug 15, 2014·Journal of Virology·Pawel ZmoraStephanie Bertram

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.